AACE Cardiometabolic Conference 2021 (Videos)

Comprehensive Update in Cardiometabolic Medicine, Diabetes, Obesity, Cardiovascular Disease, and Chronic Kidney Disease

Overview

The AACE Cardiometabolic Conference 2021 is a premier multidisciplinary educational program developed by the American Association of Clinical Endocrinology to address the rapidly evolving field of cardiometabolic medicine. This CME-accredited conference brings together leading experts in endocrinology, cardiology, nephrology, obesity medicine, and primary care to explore the latest evidence-based approaches for managing patients with interconnected metabolic and cardiovascular disorders.

Through state-of-the-art lectures, expert panel discussions, clinical case reviews, workshops, and translational medicine updates, participants gain practical strategies for improving outcomes in patients with type 2 diabetes, obesity, cardiovascular disease, chronic kidney disease, dyslipidemia, hypertension, and related metabolic conditions.

The program emphasizes personalized medicine, emerging therapies, and implementation of current clinical guidelines to help clinicians optimize long-term cardiometabolic health.

Course Specifications

Format

• CME Video Lectures
• Expert Panel Discussions
• Clinical Workshops
• Abstract Presentations
• On-Demand Educational Content

Course Year

2021

Accreditation

• 12.5 CME/CE Credits

Educational Level

Intermediate to Advanced

Specialty

Cardiometabolic Medicine

Learning Objectives

Upon completion of this activity, participants should be able to:

• Apply current clinical practice guidelines for cardiometabolic disease.
• Optimize treatment strategies for type 2 diabetes and cardiovascular disease.
• Improve management of obesity and obesity-related complications.
• Evaluate cardiovascular and renal risk in high-risk patients.
• Implement evidence-based therapies for chronic kidney disease.
• Utilize emerging diabetes technologies in clinical practice.
• Understand the role of GLP-1 receptor agonists and SGLT2 inhibitors.
• Address barriers to lifestyle modification and chronic disease management.
• Personalize treatment plans for diverse patient populations.
• Integrate recent cardiometabolic clinical trial data into patient care.

Core Topics Covered

Type 2 Diabetes and Cardiovascular Disease

Topics Include

• Cardiovascular Risk Reduction
• Diabetes Management Strategies
• ASCVD Prevention
• Heart Failure in Diabetes
• Individualized Glycemic Targets
• Comprehensive Risk Factor Control

Participants learn how diabetes management directly influences cardiovascular outcomes.

Obesity Medicine

Topics Include

• Obesity Pathophysiology
• Medical Weight Management
• Lifestyle Interventions
• Pharmacologic Obesity Treatment
• Long-Term Weight Maintenance
• Cardiometabolic Consequences of Obesity

Review of modern approaches to obesity as a chronic disease.

Cardiovascular Risk Management

Topics Include

• Atherosclerotic Cardiovascular Disease (ASCVD)
• Primary Prevention
• Secondary Prevention
• Risk Stratification
• Lipid Management
• Hypertension Control

Special emphasis is placed on reducing long-term cardiovascular morbidity and mortality.

Heart Failure and Cardiometabolic Disease

Topics Include

• Heart Failure Prevention
• HFpEF
• HFrEF
• Diabetes and Heart Failure
• Novel Cardiometabolic Therapies
• Guideline-Directed Medical Therapy

Participants explore the growing intersection between endocrinology and heart failure management.

Chronic Kidney Disease (CKD)

Topics Include

• Diabetic Kidney Disease
• CKD Progression Prevention
• Renal Protection Strategies
• Cardiorenal Syndrome
• Evidence-Based CKD Management
• Risk Assessment

Review of therapies that improve both renal and cardiovascular outcomes.

SGLT2 Inhibitors

A major focus of the conference.

Topics Include

• Mechanisms of Action
• Cardiovascular Benefits
• Heart Failure Outcomes
• Renal Protection
• Clinical Trial Evidence
• Practical Prescribing Strategies

GLP-1 Receptor Agonists

Topics Include

• Weight Reduction
• Glycemic Control
• Cardiovascular Outcome Trials
• Patient Selection
• Emerging Indications

Participants review the expanding role of GLP-1 therapies in cardiometabolic care.

Hypertension Management

Topics Include

• Contemporary Blood Pressure Guidelines
• Resistant Hypertension
• Risk Reduction Strategies
• Individualized Treatment Approaches

Dyslipidemia

Topics Include

• LDL Cholesterol Reduction
• Statin Therapy
• Non-Statin Lipid Therapies
• Hypertriglyceridemia
• Cardiovascular Risk Modification

Diabetes Technology

Topics Include

• Continuous Glucose Monitoring (CGM)
• Digital Health Tools
• Remote Monitoring
• Technology Integration in Clinical Practice

Participants learn how technology can improve diabetes outcomes and patient engagement.

NASH and NAFLD

Topics Include

• Non-Alcoholic Fatty Liver Disease
• Non-Alcoholic Steatohepatitis
• Metabolic Syndrome
• Liver Disease Progression
• Emerging Therapies

Review of liver disease within the broader context of cardiometabolic health.

Lifestyle Medicine and Wellness

Topics Include

• Nutrition
• Exercise Prescriptions
• Behavioral Modification
• Long-Term Adherence Strategies
• Patient Engagement

Special attention is given to overcoming barriers that prevent successful lifestyle modification.

Personalized Cardiometabolic Care

Topics Include

• Precision Medicine
• Risk-Based Treatment Selection
• Individualized Therapy
• Shared Decision-Making
• Health Equity

Educational Features

Multidisciplinary Faculty

Features experts from endocrinology, cardiology, nephrology, obesity medicine, and primary care.

Evidence-Based Updates

Focused on contemporary clinical guidelines and landmark cardiometabolic trials.

Translational Medicine

Bridges cutting-edge research with practical clinical application.

Patient-Centered Approach

Emphasizes individualized care plans designed to improve long-term outcomes.

Target Audience

Physicians

• Endocrinologists
• Cardiologists
• Nephrologists
• Internal Medicine Physicians
• Family Medicine Physicians
• Obesity Medicine Specialists

Advanced Practice Providers

• Nurse Practitioners
• Physician Assistants

Allied Health Professionals

• Pharmacists
• Diabetes Educators
• Dietitians
• Nurses

Why Choose This Course?

• Comprehensive coverage of modern cardiometabolic medicine.
• Strong focus on diabetes, obesity, cardiovascular disease, and CKD.
• Reviews the latest clinical practice guidelines.
• Covers rapidly evolving therapies including GLP-1 RAs and SGLT2 inhibitors.
• Multidisciplinary approach to chronic disease management.
• Ideal for clinicians seeking practical, evidence-based updates.

Topics: 

• – Day1-01- Informational Session Diabetes Survey Results
  – Day1-02- Informational Session AACE’s Obesity Health Research Initiative
  – Day1-03- Informational Session AACE’s Initiative on Clinical Interpretation of CGM Reports
  – Day1-04- Clinical Conversations on Diabetes Technology
  – Day1-05- Cardiometabolic Health What is New in Adrenal, Thyroid and Bone in 2021
  – Day2-01- Welcome and Overview
  – Day2-02- Cardiovascular Health in Women
  – Day2-03- Post Bariatric Surgery Results- Surgeon and Endocrinologist
  – Day2-04- Fatty Liver Through the Ages
  – Day2-05- Structural Inequities and Diabetes Challenges and Solutions
  – Day2-06- 2021 Controversies in Diabetes – Workshop Session 1
  – Day2-07- Beyond LDL – Workshop Session 1
  – Day2-09- Lifestyle Interventions for Cardiometabolic Health – Workshop Session 1
  – Day2-10- The Emerging Role of the Liver – Workshop Session 1
  – Day2-11- Beyond LDL – Workshop Session 2
  – Day2-12- Lifestyle Interventions for Cardiometabolic Health – Workshop Session 2
  – Day2-13- Factors Associated With High Glycemic Variability in Patients With Diabetes Hospitalized With COVID-19
  – Day2-14- The Efficacy and Safety of a SGLT2 Inhibitors on Body Weight in Obese Patients Without Diabetes
  – Day2-15- Are We Missing NAFLD Fibrosis in Our Patients – One Endocrinologist’s Clinic Experience
  – Day3-01- Welcome and Recap of Saturday Sessions
  – Day3-02- AACE DEI Initiative
  – Day3-03- Emerging Topics in Kidney Disease Management Non-Steroidal Mineralocorticoid Receptor Treatment
  – Day3-04- Professional Burnout Recognition and Management
  – Day3-05- Is Obesity Curable
  – Day3-06- Diabetes Technology Related Pumps and CGM Systems- Workshop Session 3
  – Day3-07- Estrogen and Testosterone Use in Cardiometabolic Health – Workshop Session 3
  – Day3-08- Implications of Social Determinants of Health in Chronic Disease Management – Workshop Session 3
  – Day3-09- Is There a Perfect Diet for Cardiometabolic Health – Workshop Session 3
  – Day3-10- Diabetes Technology Related Pumps and CGM Systems- Workshop Session 4
  – Day3-11- Implications of Social Determinants of Health in Chronic Disease Management – Workshop Session 4
  – Day3-12- Practicalities of SGLT2i and GLP1RA in Both CVD and Kidney Disease – Workshop Session 4
  – Day3-13- Estrogen and Testosterone Use in Cardiometabolic Health – Workshop Session 5
  – Day3-14- Is There a Perfect Diet for Cardiometabolic Health – Workshop Session 5
  – Day3-15- Practicalities of SGLT2i and GLP1RA in Both CVD and Kidney Disease – Workshop Session 5
  – Day3-16- Closing Remarks

Release Date : October 8- 10, 2021